NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
EPS Diluted Over TimeExpanding
Percentile Rank60
Studio
Year-over-Year Change

Diluted earnings per share

Latest
-1.75
↑ 14% vs avg
Percentile
P60
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-2.02
Historical baseline
PeriodValueYoY Change
2025-1.75+31.6%
2024-2.56-19.1%
2023-2.15-80.7%
2022-1.19+64.4%
2021-3.34-190.4%
2020-1.15-